Abounit S, Wu JW, Duff K, Victoria GS, Zurzolo C (2016) Tunneling nanotubes: a possible highway in the spreading of tau and other prion-like proteins in neurodegenerative diseases. Prion 10:344–351. https://doi.org/10.1080/19336896.2016.1223003

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhaskar K, Hobbs GA, Yen SH, Lee G (2010) Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy. Neuropathol Appl Neurobiol 36:462–477. https://doi.org/10.1111/j.1365-2990.2010.01103.x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol (Berl) 112:389–404. https://doi.org/10.1007/s00401-006-0127-z

Article  PubMed  Google Scholar 

Bravo CP, Naguib SA, Gan L (2024) Cellular and pathological functions of tau. Nat Rev Mol Cell Bio. https://doi.org/10.1038/s41580-024-00753-9

Article  Google Scholar 

Briner A, Götz J, Polanco JC (2020) Fyn kinase controls tau aggregation. Cell Rep. https://doi.org/10.1016/j.celrep.2020.108045

Article  PubMed  Google Scholar 

Chu F, Xu JM, Wang Y, Li YJ, Wang YL, Liu ZJ et al (2022) Novel mutations in GJB1 trigger intracellular aggregation and stress granule formation in X-linked Charcot-Marie-tooth disease. Front Neurosci-Switz. https://doi.org/10.3389/fnins.2022.972288

Article  Google Scholar 

Clavaguera F, Akatsu H, Fraser G, Crowther RA, Frank S, Hench J et al (2013) Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc Natl Acad Sci U S A 110:9535–9540. https://doi.org/10.1073/pnas.1301175110

Article  PubMed  PubMed Central  Google Scholar 

Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A et al (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11:909–913. https://doi.org/10.1038/ncb1901

Article  CAS  PubMed  PubMed Central  Google Scholar 

Congdon EE, Ji CY, Tetlow AM, Jiang YX, Sigurdsson EM (2023) Tau-targeting therapies for Alzheimer disease: current status and future directions. Nat Rev Neurol 19:715–736. https://doi.org/10.1038/s41582-023-00883-2

Article  PubMed  PubMed Central  Google Scholar 

Creekmore BC, Watanabe R, Lee EB (2024) Neurodegenerative disease tauopathies. Annu Rev Pathol-Mech 19:345–370. https://doi.org/10.1146/annurev-pathmechdis-051222-120750

Article  CAS  Google Scholar 

De Gerando AM, Welikovitch LA, Khasnavis A, Commins C, Glynn C, Chun JE et al (2023) Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau. Acta Neuropathol (Berl) 146:191–210. https://doi.org/10.1007/s00401-023-02600-1

Article  CAS  Google Scholar 

Düster R, Kaltheuner IH, Schmitz M, Geyer M (2021) 1,6-Hexanediol, commonly used to dissolve liquid-liquid phase separated condensates, directly impairs kinase and phosphatase activities. J Biol Chem. https://doi.org/10.1016/j.jbc.2021.100260

Article  PubMed  PubMed Central  Google Scholar 

Götz J, Halliday G, Nisbet RM (2019) Molecular pathogenesis of the tauopathies. Annu Rev Pathol-Mech 14:239–261. https://doi.org/10.1146/annurev-pathmechdis-012418-012936

Article  CAS  Google Scholar 

Guo T, Noble W, Hanger DP (2017) Roles of tau protein in health and disease. Acta Neuropathol 133:665–704. https://doi.org/10.1007/s00401-017-1707-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hanger DP, Anderton BH, Noble W (2009) Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol Med 15:112–119. https://doi.org/10.1016/j.molmed.2009.01.003

Article  CAS  PubMed  Google Scholar 

Ho GJ, Hashimoto M, Adame A, Izu M, Alford MF, Thal LJ et al (2005) Altered p59Fyn kinase expression accompanies disease progression in Alzheimer’s disease: implications for its functional role. Neurobiol Aging 26:625–635. https://doi.org/10.1016/j.neurobiolaging.2004.06.016

Article  CAS  PubMed  Google Scholar 

Holmes BB, Furman JL, Mahan TE, Yamasaki TR, Mirbaha H, Eades WC et al (2014) Proteopathic tau seeding predicts tauopathy in vivo. Proc Natl Acad Sci U S A 111:E4376–E4385. https://doi.org/10.1073/pnas.1411649111

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iannuzzi F, Sirabella R, Canu N, Maier TJ, Annunziato L, Matrone C (2020) Fyn tyrosine kinase elicits amyloid precursor protein Tyr682 phosphorylation in neurons from Alzheimer’s disease patients. Cells. https://doi.org/10.3390/cells9081807

Article  PubMed  PubMed Central  Google Scholar 

Iba M, Guo JL, McBride JD, Zhang B, Trojanowski JQ, Lee VM (2013) Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer’s-like tauopathy. J Neurosci 33:1024–1037. https://doi.org/10.1523/JNEUROSCI.2642-12.2013

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J et al (2010) Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer’s disease mouse models. Cell 142:387–397. https://doi.org/10.1016/j.cell.2010.06.036

Article  CAS  PubMed  Google Scholar 

Jain AK, Jaiswal AK (2007) GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2. J Biol Chem 282:16502–16510. https://doi.org/10.1074/jbc.M611336200

Article  CAS  PubMed  Google Scholar 

Kaufman AC, Salazar SV, Haas LT, Yang J, Kostylev MA, Jeng AT et al (2015) Fyn inhibition rescues established memory and synapse loss in Alzheimer mice. Ann Neurol 77:953–971. https://doi.org/10.1002/ana.24394

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaufman SK, Del Tredici K, Thomas TL, Braak H, Diamond MI (2018) Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer’s disease and PART. Acta Neuropathol (Berl) 136:57–67. https://doi.org/10.1007/s00401-018-1855-6

Article  CAS  PubMed  Google Scholar 

Larson M, Sherman MA, Amar F, Nuvolone M, Schneider JA, Bennett DA et al (2012) The complex PrP(c)-Fyn couples human oligomeric Abeta with pathological tau changes in Alzheimer’s disease. J Neurosci 32:16857–16871a. https://doi.org/10.1523/JNEUROSCI.1858-12.2012

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lauretti E, Dincer O, Praticò D (2020) Glycogen synthase kinase-3 signaling in Alzheimer’s disease. Bba-Mol Cell Res. https://doi.org/10.1016/j.bbamcr.2020.118664

Article  Google Scholar 

Li C, Götz J (2017) Somatodendritic accumulation of Tau in Alzheimer’s disease is promoted by Fyn-mediated local protein translation. EMBO J 36:3120–3138. https://doi.org/10.15252/embj.201797724

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li C, Götz J (2017) Tau-based therapies in neurodegeneration: opportunities and challenges. Nat Rev Drug Discov 16:863–883. https://doi.org/10.1038/nrd.2017.155

Article  CAS  PubMed  Google Scholar 

Li WW, Pang YA, Wang Y, Mei F, Guo MM, Wei YP et al (2023) Aberrant palmitoylation caused by a ZDHHC21 mutation contributes to pathophysiology of Alzheimer’s disease. Bmc Med. https://doi.org/10.1186/s12916-023-02930-7

Article